Covexin Plus (Canada)

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Tetani-Perfringens Types C & D Bacterin-Toxoid

FOR USE IN ANIMALS ONLY

Covexin Plus Indications

COVEXIN® PLUS vaccine is recommended for the vaccination of healthy cattle 3 months of age or older as an aid in the prevention of disease caused by Clostridium tetani, C. chauvoei, C. septicum, C. novyi Type B, C. haemolyticum, C. sordellii, and C. perfringens Types C & D. Immunity is also provided as an aid in the prevention of diseases caused by the beta and epsilon toxins of an additional organism, C. perfringens Type B. Although C. perfringens Type B is not a significant problem in Canada, immunity is derived from a combination of Type C (beta) and Type D (epsilon) C. perfringens fractions.

ADMINISTRATION AND DOSAGE: Shake well. Inject 2 mL subcutaneously followed by a 2 mL dose 3 weeks later. Calves vaccinated at 3-6 months of age should be given a 3rd vaccination 6 weeks later with either COVEXIN® PLUS, or another vaccine containing C. perfringens Type D epsilon toxoid, to aid in the prevention of disease caused by C. perfringens Type D. Revaccinate annually with 2 mL prior to periods of extreme risk or parturition.

PRESERVATIVES: Gentamicin and thimerosal.

Covexin Plus Caution

Store at 2°-7°C. Do not freeze. Use entire contents when first opened. Dispose of containers and all unused vaccine according to local biohazardous waste disposal regulations. Transient swelling may occur post-vaccination. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

Manufactured by: Schering-Plough Animal Health Limited, Upper Hutt, New Zealand

For: Intervet Canada Corp., Kirkland, Québec H9H 4M7

1 866 683-7838 (Canada)

CPN: 1208126.4